Suven Pharmaceuticals Ltd
Company Profile
Business description
Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.
Contact
No. 202, A-Wing, Galaxy Towers
Plot No.1, Hyderabad Knowledge City
TSIIC, Raidurg
HyderabadTG500081
INDT: +91 4023549414
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,052
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,913.90 | 352.20 | 4.66% |
| CAC 40 | 7,156.37 | 293.35 | 4.27% |
| DAX 40 | 20,634.92 | 964.04 | 4.90% |
| Dow JONES (US) | 39,434.51 | 1,173.94 | -2.89% |
| FTSE 100 | 7,928.08 | 248.60 | 3.24% |
| HKSE | 20,681.78 | 417.29 | 2.06% |
| NASDAQ | 16,395.93 | 729.05 | -4.26% |
| Nikkei 225 | 34,609.00 | 2,894.97 | 9.13% |
| NZX 50 Index | 12,201.43 | 394.88 | 3.34% |
| S&P 500 | 5,262.92 | 193.98 | -3.55% |
| S&P/ASX 200 | 7,709.60 | 334.60 | 4.54% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |